Fabtech Cleanrooms
H1 FY27 revenue rose 75% to ₹133 Cr and PAT 55%, but margins stayed flat at 7.7% and receivables reached ₹129 Cr. Management's 70-80% FY27 growth claim is a sharp pivot from its 20-30% guidance.
ALFA Concalls
Every earnings call, live and summarised
Earnings calls
Every Fabtech Cleanrooms earnings call we streamed: the live audio and our summary of what management said.
H1 FY27 revenue rose 75% to ₹133 Cr and PAT 55%, but margins stayed flat at 7.7% and receivables reached ₹129 Cr. Management's 70-80% FY27 growth claim is a sharp pivot from its 20-30% guidance.
H1 FY27 revenue rose 75% to ₹133 Cr and PAT 55%, but margins stayed flat at 7.7% and receivables reached ₹129 Cr. Management's 70-80% FY27 growth claim is a sharp pivot from its 20-30% guidance.
FY27 growth 70-80%; ~10% FY27 EBITDA margin; H2 margin above 12%; order book ₹468 Cr.
Fabtech (FABCLEAN) transitioned from pharma-only to a high-tech infrastructure player. FY26 consolidated revenue reached ₹221.72 Cr with 10.4% EBITDA margins, driven by strategic acquisitions and solar/data center expansion.
Fabtech Technologies reported H2FY26 consolidated revenue of ₹221.72cr (up 46.9% YoY) and PAT of ₹15.82cr (up 19%). The company is pivoting from life sciences to high-growth non-pharma sectors like solar and data centers.
Fabtech reported strong top-line growth of 47% YoY for FY26 but suffered margin compression due to strategic under-pricing in new sectors like Solar and Semiconductor to build credentials.
Fabtech reported FY26 consolidated total income of ₹221.72 Cr with PAT of ₹15.82 Cr, transitioning into high-growth sectors like data centers and semiconductors.
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.